For many decades, neuroscientists believed there was a "critical period" in which the brain could learn to make sense of visual input, and that this window closed around the age of 6 or 7.
May 1, 2023
0
95
An Australian research team led by QIMR Berghofer has succeeded in introducing a vascular system into tiny living and beating model human heart muscles, an achievement which it's hoped will accelerate progress toward the ...
Apr 27, 2023
0
101
A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation ablation, according to late breaking science presented at EHRA 2023, ...
Apr 18, 2023
0
11
New research has debunked the idea that there is an "obesity paradox," whereby patients with heart failure who are overweight or obese are thought to be less likely to end up in hospital or die than people of normal weight.
Mar 21, 2023
0
52
For many people who have heart failure, supervised exercise training is safe and may offer substantial improvement in exercise capacity and quality of life, even more than medications, according to a new, joint scientific ...
Mar 21, 2023
0
3
Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 times as likely to prescribe mineralocorticoid receptor antagonists (MRAs), a guideline-recommended class of heart failure ...
Mar 7, 2023
0
16
Recent studies have provided strong evidence that patients with heart failure can benefit from medical therapies that can reduce risk of worsening symptoms and extend patients' lives. But despite new guidelines, adoption ...
Mar 6, 2023
0
9
In a world-first randomized study, catheter ablation has been shown to reverse heart failure with preserved ejection fraction (HFpEF) in patients with both HFpEF and atrial fibrillation (AF).
Mar 2, 2023
0
36
Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction. The therapy benefited patients by ...
Feb 27, 2023
0
410
According to a new article in Cardiovascular Innovations and Applications, sodium-glucose cotransporter-2 (SGLT2) inhibitors have been found to ameliorate major adverse cardiovascular events in patients with heart failure ...
Feb 16, 2023
0
1
